4.1. CD90+ Cells Derived from Ascitic Fluid of an HCC Patient Develop Resistance against Combined Targeting of AKT/mTOR by Restauration of AKT and mTOR Signaling. This evidence concerns the gene MTOR and hepatocellular carcinoma.